Current treatment pathways in ALS: a European perspective

Understanding the timeline from symptom onset to diagnosis remains a challenge in neurological disorders like ALS. Prior research has shown that delays in diagnosis can affect treatment outcomes. However, the exact patterns of physician consultation and diagnostic procedures across Europe are not fully understood. This gap motivated a closer look at how patients navigate the healthcare system before receiving a confirmed diagnosis. No prior work had resolved the regional differences in diagnostic delays or the role of primary care physicians in the process. The European healthcare landscape varies significantly, which may influence patient pathways. Establishing baseline data on diagnostic timelines is essential for improving care coordination. The use of diagnostic tools such as EMG, MRI, and CT has been documented in general, but their impact on diagnostic delays remains unclear. This study aims to clarify these patterns within the European context.

The purpose of this study was to analyze the diagnostic and treatment pathways for ALS patients in Europe. The authors sought to quantify the time intervals between symptom onset, initial consultation, and neurology referral. They aimed to identify regional variations in these timelines and assess the role of diagnostic procedures. The motivation stemmed from the need to better understand how early patients access specialist care. Delays in diagnosis can affect treatment initiation and patient outcomes. The study focused on the European subset of an international survey to provide region-specific insights. By examining consultation patterns and diagnostic methods, the authors aimed to highlight areas for improvement in care delivery. This work contributes to the broader goal of optimizing ALS management strategies.

The study analyzed data from a European subgroup of 91 patients included in an international ALS survey. Researchers collected information on the time intervals between symptom onset, first physician consultation, and neurology referral. They categorized patients based on symptom onset type—limb or bulbar—and examined regional differences. Diagnostic procedures such as EMG, MRI, and CT were recorded to assess their frequency and potential impact on delays. The authors compared diagnostic timelines across countries like Germany, Italy, and Spain. Patient pathways were evaluated to determine the role of general practitioners versus neurologists in the diagnostic process. The study used descriptive statistics to summarize the data and identify trends. The focus was on synthesizing patterns in clinical practice across Europe.

The mean time from symptom onset to first consultation was 4.9 months, with an additional 6 months before seeing a neurologist. The average total time to diagnosis was 17.8 months, with limb-onset patients taking 18.5 months and bulbar-onset patients 17.5 months. Upper-limb cases were diagnosed faster (15.5 months) than lower-limb cases (21.8 months). Fifty-one percent received a diagnosis within 15 months, and 74% within 24 months. Fifty-five percent were diagnosed within 4 months of seeing a neurologist. General practitioners were the first point of contact in 68% of cases. When a neurologist was first consulted (7% in Germany, 13% in Italy), diagnosis occurred within 14 months in 67% of cases. EMG was performed in nearly all patients, while MRI and CT were frequently used.

The authors concluded that diagnostic delays remain a significant issue in ALS care across Europe. The study highlights the importance of early neurology referral to reduce the time to diagnosis. Patients with limb-onset symptoms, particularly lower-limb, faced longer delays. The role of general practitioners as the first point of contact suggests a need for improved awareness and triage. The use of EMG was widespread, but MRI and CT may have contributed to diagnostic delays. The authors propose that streamlining access to neurology services could improve outcomes. They emphasize the need for standardized diagnostic protocols to reduce variability. These findings suggest that targeted interventions could enhance care coordination for ALS patients.